AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Lopinavir; Ritonavir in Nigeria
4 products registered with NAFDAC — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Lopinavir 200 mg/Ritonavir 50 mg** Tablet | A4-3852 | Phillips Pharmaceuticals (Nigeria) Limited | active | 1 May 2029 |
| Alltera 50 Granules Granules | A4-100094 | Healthline Limited | active | 27 Sept 2026 |
| Ritocom Tablets (duplicate) Tablet | B4-0455 | Hetero Labs Nigeria Limited | active | 20 Dec 2025 |
| Lopinavir/Ritonavir 200 mg/50 mg Tablet Tablet | A4-1023 | Healthline Limited | active | 20 Dec 2025 |
Lopinavir; Ritonavir — NAFDAC Registration Details
NAFDAC (Nigeria) has 4 registered products containing Lopinavir; Ritonavir, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Lopinavir; Ritonavir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.